Sunfox Technologies Raises $7M Series A for Portable AI Cardiac Diagnostics

Sunfox Technologies Raises $7M Series A

Sunfox Technologies, a Dehradun-based medical technology company, has raised $7 million in a Series A round led by Lashit Sanghvi. The round also includes participation from Ashish Kacholia, 3one4 Capital, and Alchemy Capital. The funding was announced on October 7, 2026.

What Sunfox Technologies Does

Founded in 2016, Sunfox Technologies builds portable, AI-enabled cardiac diagnostics. Its flagship Spandan platform is a medical-grade portable ECG that lets frontline health workers, clinics, and patients record an ECG with a smartphone and share it with remote doctors for interpretation.

A second layer, Spandan One, is a digital layer that supports remote ECG review and tele-ECG networks through a hub-and-spoke model in public-health systems. That architecture is designed to connect frontline capture points with centralized interpretation capacity — a common requirement in large public-health deployments.

Deployment and Regulatory Footprint

According to the company, around 60,000 Spandan devices have been deployed across more than 20,000 Indian villages, screening roughly 5 million patients a year. Sunfox also says its products are used in more than 15 countries.

The company holds regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa, and is pursuing clearances in the United States and European Union.

The Round at a Glance

• Company: Sunfox Technologies
• Round type: Series A
• Amount raised: $7,000,000 USD
• Announced: October 7, 2026
• Lead investor: Lashit Sanghvi
• Additional investors: Ashish Kacholia, 3one4 Capital, Alchemy Capital
• Stage: Series A

Why the Raise Matters

Sunfox operates in a segment of medical technology where distribution and regulatory reach matter as much as the device itself. A portable ECG that pairs with a smartphone lowers the hardware barrier for frontline screening, while the Spandan One tele-ECG layer addresses the interpretation bottleneck that typically limits how many patients a rural screening program can actually serve.

The company's existing footprint — tens of thousands of devices across more than 20,000 Indian villages and a stated screening volume of roughly 5 million patients a year — gives it a deployment base that is difficult to replicate quickly. Its multi-country regulatory approvals across India and several African markets provide a foundation for expansion beyond its home market.

What to Watch

The stated pursuit of United States and European Union clearances is the key forward-looking item. Success there would open substantially larger addressable markets for the Spandan platform and its tele-ECG network layer.

Summary

Sunfox Technologies raised a $7 million Series A led by Lashit Sanghvi, with Ashish Kacholia, 3one4 Capital, and Alchemy Capital participating, announced October 7, 2026. The Dehradun-based company, founded in 2016, builds the Spandan portable medical-grade ECG and the Spandan One tele-ECG digital layer. Around 60,000 devices have been deployed across more than 20,000 Indian villages, screening roughly 5 million patients a year, with products used in more than 15 countries and regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa.